🇺🇸 FDA
Pipeline program

AMG 193, AMG 193, AMG 193

20210023

Phase 2 small_molecule active

Quick answer

AMG 193, AMG 193, AMG 193 for Advanced MTAP-null solid tumors is a Phase 2 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Amgen Technology (Ireland) UC
Indication
Advanced MTAP-null solid tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials